Tosoh (4042) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Nov, 2025Executive summary
Net sales for the first half of FY2026 declined to ¥499.1 billion, down 5.4% year-over-year, mainly due to lower selling prices from decreased naphtha prices, a stronger yen, and reduced shipments from extended maintenance at the Nanyo Complex.
Operating income decreased 5.6% year-over-year to ¥44.7 billion, impacted by unfavorable inventory fluctuations and increased fixed costs, despite improved terms of trade and sales growth in the Engineering Group.
Ordinary income rose 1.4% year-over-year to ¥45.7 billion, supported by improved foreign exchange gains.
Income attributable to owners of parent dropped 70.4% year-over-year to ¥7.4 billion, primarily due to a ¥19.1 billion impairment loss at Tosoh SMD, Inc.
Financial highlights
Gross profit for the period was ¥124.2 billion, down from ¥126.2 billion a year earlier.
Basic earnings per share fell to ¥23.21 from ¥78.32 year-over-year.
Comprehensive income decreased to ¥11.3 billion from ¥39.9 billion year-over-year.
Cash and cash equivalents at period end were ¥133.1 billion, down ¥5.7 billion from the previous period.
Non-operating income improved due to better foreign exchange gains/losses.
Outlook and guidance
Full-year net sales forecast revised down to ¥1,020.0 billion (down 2.9% from previous forecast), with operating and ordinary income both forecast at ¥103.0 billion.
Income attributable to owners of parent forecast at ¥38.0 billion, a 34.5% decrease year-over-year.
Basic earnings per share forecast at ¥119.53.
Annual dividend forecast maintained at ¥100 per share, with up to ¥25 billion in share buybacks planned.
Latest events from Tosoh
- Profits fell sharply on lower sales and a major impairment loss, despite engineering growth.4042
Q3 20265 Feb 2026 - Operating income and dividends increased, with strong segment gains and upward guidance revision.4042
Q3 202510 Sep 2025 - Profits fell on weaker petrochemical and chlor-alkali results, but guidance is unchanged.4042
Q1 20265 Aug 2025 - Sales and profits rose on higher prices and FX gains; outlook and dividend unchanged.4042
Q1 202513 Jun 2025 - Sales and operating income surged, but net profit fell amid forex losses and market uncertainty.4042
Q2 202513 Jun 2025 - Operating and net sales rose, with strong segment growth and robust future profit guidance.4042
Q4 20256 Jun 2025